Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study
Brigham and Women's Hospital · Fox Chase Cancer Center · +3 more institutions
Abstract
Brain metastases are associated with significant morbidity and mortality. Population-level data describing the incidence and prognosis of patients with brain metastases are lacking. The aim of this study was to characterize the incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy using recently released data from the Surveillance, Epidemiology, and End Results (SEER) program.
We identified 1302166 patients with diagnoses of nonhematologic malignancies originating outside of the CNS between 2010 and 2013 and described the incidence proportion and survival of patients with brain metastases.
Citation impact
- FWCI
- 29.54
- Percentile
- 100%
- References
- 35
Authors
13- DCDaniel Cagney
Brigham and Women's Hospital, Fox Chase Cancer Center, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
- AMAllison Martin
Brigham and Women's Hospital, Fox Chase Cancer Center, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
- PJPaul J. Catalano
Brigham and Women's Hospital, Fox Chase Cancer Center, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
- AJAmanda J. Redig
Brigham and Women's Hospital, Fox Chase Cancer Center, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
- NUNancy U. Lin
Brigham and Women's Hospital, Fox Chase Cancer Center, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
Topics & keywords
- Medicine
- Malignancy
- Brain metastasis
- Lung cancer
- Incidence (geometry)
- Cancer
- Oncology
- Internal medicine
- Good health and well-being